ACT CAPITAL MANAGEMENT, LLC
WAYNE, PA · Quarter end: Jun 30, 2026 · Filed with SEC: Jul 29, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$153.1M2026 Q2
Positions62
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.66.0%
Top Holdings
KRYS
Krystal Biotech
10.9%
TGTX
TG Therapeutics
9.0%
ABVX
Abivax S.A.
8.4%
CVX
Chevron
8.1%
EXMOC
Exxon Mobil
7.0%
ARWR
Arrowhead Pharmaceuticals
5.9%
VKTX
Viking Therapeutics
5.3%
CELC
Celcuity
4.2%
New / Increased
No prior quarter data
Reduced / Exited
No prior quarter data
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.